Join us in congratulating Incoming Editor-in-Chief Michael Lotze and Deputy Editor-in-Chief Sjoerd van der Burg – Journal for ImmunoTherapy of Cancer
Journal for ImmunoTherapy of Cancer shared a post on LinkedIn:
“Join us in congratulating Incoming Editor-in-Chief Michael Lotze of the University of Pittsburgh on his recently announced appointment by the Society for Immunotherapy of Cancer (SITC). With over 30 years in the field, Dr. Lotze brings enthusiasm and passion for advancing the journal and the field of cancer immunotherapy as a whole. We look forward to working with him and JITC Interim EIC James Gulley as leadership is transferred over the next several months.
We are also thrilled to share that Sjoerd van der Burg of Oncode Institute and Leiden University has been promoted to the position of Deputy Editor-in-Chief. Dr. van der Burg most recently served as JITC’s Interim Deputy Editor-in-Chief in 2023. His leadership in an interim capacity has been instrumental in ensuring a smooth transition with a continued focus on advancing top research to support the future development of the field.
Read more about JITC’s incoming leadership here.
Thank you to all who expressed interest in serving as JITC’s next Editor-in-Chief! Special thanks to the SITC Publications Task Force and SITC Board of Directors for their thoughtful consideration of all applicants.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023